What is Diabetes Type 2?
Diabetes type 2 is a condition in which the body is resistant to insulin resulting in high blood sugar levels. Symptoms include fatigue, hunger, thirst, increased urination, and tingling in feet and hands.
Treatment for diabetes type 2 includes medication, diet, and exercise. Common drug classes used to treat diabetes type 2 are biguanides, insulins, sulfonylureas, gliptins, glitazones, sulfonylurea / biguanide combinations, gliptin / biguanide combinations, GLP-1 agonists, ergot derivatives, glinides, glitazone / biguanide combinations, alpha glucosidase inhibitors, amlyn analogues, glitazone / sulfonylurea combinations, gliptin / statin combinations, gliptin / glitazone combinations, SGLT2 inhibitors, and glinide / biguanide combinations.
Savings Tips for Diabetes Type 2
see all savings tips
July 06, 2016
In June 2016, the FDA issued a safety alert for canagliflozin (Invokana, Invokamet), used to treat type 2 diabetes.
Now, another warning has been issued, for Invokana and Invokamet along with another similar diabetes medication, dapagliflozin (Farxiga and Xigduo XR).
According to the FDA, canagliflozin and dapagliflozin may cause an increased risk of acute kidney injury. The previous warning for canagliflozin was for an increased risk of foot and leg amputations—all serious stuff. See More
June 23, 2016
Jentadueto XR (metformin/linagliptin) is the newest once-daily combination drug approved by the FDA to treat type 2 diabetes.
Combination drugs can also be a convenient way to join together two drugs that work differently to treat a particular health condition, and extended release versions like Jentadueto XR mean you only need to take your prescription once per day. In addition, many medications are combined because they work better together than either medication alone. See More
June 08, 2016
The FDA has issued a safety alert for medications containing canagliflozin, a newer drug used to treat type 2 diabetes.
According to the FDA, medications containing canagliflozin (Invokana and Invokamet) may cause an increased risk of leg and foot amputations.
Do diabetics already have an increased risk of leg and foot amputations?
Yes. Diabetics have a higher risk of leg and foot amputations compared to a person who does not have diabetes. See More
Popular Diabetes Type 2 Drugs
see all 122 drugs
Note: Popularity is based on total prescriptions for the brand and generic versions of each drug,
regardless of the condition being treated. Some drugs are prescribed for multiple conditions.